Global Antiparasitic Drugs Market to Reach $33.64 Billion by 2029, Growing at 6.9% CAGR

What combination of drivers is leading to accelerated growth in the antiparasitic drugs market?
The rise in occurrences of diseases spread by vectors is anticipated to accelerate the expansion of the antiparasitic drugs market. Vector-borne diseases are infectious illnesses passed onto humans or other creatures via the bites of arthropods, predominantly insects such as mosquitoes, ticks and flies. Diseases like malaria, dengue and yellow fever are typical examples. Antiparasitic drugs are instrumental in restraining the spread of vector-borne diseases by targeting and annihilating the accountable parasites. Certain antiparasitic drugs, like chloroquine, doxycycline and atovaquone-proguanil, are typically employed to treat malaria. For instance, the Centers for Disease Control and Prevention, a U.S Government agency, stated in June 2024, that from January to June 2024, over 9.7 million dengue cases were documented across the Americas, a significant increase compared to the 4.6 million cases reported in 2023. The report highlighted 1,498 dengue cases in Puerto Rico, and 745 cases identified among U.S. citizens returning from impacted areas. Accordingly, the escalating incidence of vector-borne diseases is fuelling the growth of the antiparasitic drugs market. Considering the Antiparasitic Drugs Market Driver, the pervasive existence of parasitic infections is predicted to stimulate the growth of the antiparasitic drug market. These infections are instigated by tiny parasites or larger organisms that survive and flourish at their host organism's expense, often inducing harm or disease. Antiparasitic drugs are effective resources in managing and controlling parasitic infections, enhancing health outcomes and diminishing the toll of these conditions on impacted individuals and societies. As an example, in May 2024, according to Gov. UK, a UK-based government website, there were 31 rickettsial infection cases reported in EWNI in 2022, with 30 in England and 1 in Wales. The data indicated that 17 (55%) of these were confirmed cases, while 14 (45%) were considered probable cases. Hence, the extensive prevalence of parasitic infections propels the growth of the antiparasitic drug market.

Get Your Antiparasitic Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/report/antiparasitic-drugs-global-market-report

What is the projected compound annual growth rate (CAGR) of the antiparasitic drugs market from 2025 to 2034, and what factors influence it?
In recent times, the market size for antiparasitic drugs has experienced robust growth. The market value is projected to increase from $24.06 billion in 2024 to $25.75 billion in 2025, with a compound annual growth rate (CAGR) of 7.0%. The historic growth could be ascribed to the widespread occurrence of parasitic infections, resistance to currently available treatments, and global health initiatives.

The market for antiparasitic drugs is projected to witness significant expansion in the coming years, reaching $33.64 billion by 2029, with a compound annual growth rate (CAGR) of 6.9%. This growth during the forecasted period is likely due to escalating parasitic threats, climate change, vector-borne diseases, and a heightened focus on worldwide health security, as well as increased healthcare access. The period is also expected to see dominant trends such as improvements in medicinal development, targeted treatments, combination therapies, collaborations between public and private sectors, telemedicine, and remote diagnosis.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12927&type=smp

What new trends are reshaping the antiparasitic drugs market and its opportunities?
Significant market players in the antiparasitic drugs industry are prioritizing the creation of inventive products such as chewable veterinary items to enhance administration convenience and increase pet adherence. These chewable veterinary items are flavored, simple-to-give tablets or treats crafted to dispense medication to animals. They boost pet adherence by making the treatment tastier and less stressful. To exemplify, in April 2024, C.H. Boehringer Sohn AG and Co. KG, a pharmaceutical firm based in Germany, introduced NexGard Spectra for complete parasite management. NexGard SPECTRA is a tasty, soft chew offering comprehensive parasite protection for dogs, effectively addressing fleas, ticks, heartworms, and different intestinal worms in a unique monthly dose. It shows quick action by eradicating fleas within four hours of giving it and attains over 99% efficacy against multiple parasites not long after.

What are the major segments of the antiparasitic drugs market and their role in driving growth?
The antiparasitic drugs market covered in this report is segmented -

1) By Product Type: Anthelmintics, Antiprotozoals, Ectoparasiticide, Other Products
2) By Treatment: Avermectins, Bezimidazoles, Pyrimidines, Organophosphates, Imidazolesthiazoles
3) By Route of Administration: Oral, Injectable, Topical
4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:
1) By Anthelmintics: Benzimidazoles, Ivermectin, Pyrantel Pamoate, Praziquantel
2) By Antiprotozoals: Metronidazole, Tinidazole, Nitazoxanide, Pentamidine
3) By Ectoparasiticides: Permethrin, Malathion, Lindane, Fipronil
4) By Other Products: Combination Antiparasitic Drugs, Novel Antiparasitic Agents

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12927

Which regions are key players in the growth of the antiparasitic drugs market?
North America was the largest region in the antiparasitic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in antiparasitic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the key firms paving the way for growth in the antiparasitic drugs market?
Major companies operating in the antiparasitic drugs market are Pfizer Inc., Johnson & Johnson, Cadila Pharmaceuticals, Merck & Co.Inc., Bayer AG, Novartis AG, Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim group, Zoetis Inc., Eisai Co. Ltd., Covetrus Inc., IDEXX Laboratories Inc., Dr. Reddy's Laboratories, Intas Pharmaceuticals Ltd., Alkem Laboratories Ltd., Ceva Sante Animale S.A., Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Norbrook Laboratories Ltd., Mankind Pharma, Neogen Corporation, Bimeda Inc., Indoco Remedies Ltd., ECO Animal Health, Lincoln Pharmaceuticals Ltd., Laboratorios Calier.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12927&type=smp

What Is Covered In The Antiparasitic Drugs Global Market Report?

• Market Size Forecast: Examine the antiparasitic drugs market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the antiparasitic drugs market for a structured understanding.
• Key Players Overview: Analyze major players in the antiparasitic drugs market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the antiparasitic drugs market.
• Segment Contributions: Evaluate how different segments drive overall growth in the antiparasitic drugs market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the antiparasitic drugs market.
• Industry Challenges: Identify potential risks and obstacles affecting the antiparasitic drugs market.
• Competitive Landscape: Review strategic developments in the antiparasitic drugs market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.